Eton Pharmaceuticals Shares Surge Following Q3 Earnings Beat and Raised Full-Year Guidance
Eton Pharmaceuticals (ETON) saw its stock price jump over 20% in premarket trading following the release of third-quarter financial results that exceeded analyst expectations. The company's strong performance was driven by robust demand for its key rare disease treatments. In addition to the quarterly beat, the Deer Park, Illinois-based drugmaker raised its full-year financial outlook. This upward revision reflects management's confidence in sustained product demand and the company's current growth trajectory.
Tickers: $ETON